Edmunds A T, McKenzie S, Baillie E, Tooley M, Godfrey S
Br J Dis Chest. 1979 Apr;73(2):149-56.
Fourteen children with perennial asthma previously treated with beclomethasone dipropionate were studied for four months in a crossover trial to compare the efficacy of choline theophyllinate and beclomethasone dipropionate aerosol in the control of their symptoms. Assessments were made using twice daily peak flow measurements, together with daily records of symptom scores and use of extra salbutamol. Beclomethasone and oral choline theophyllinate together improved control of asthma in comparison with beclomethasone alone. Reduction of the dose of beclomethasone from 400 microgram/day caused worsening of asthma. Oral choline theophyllinate did not prevent this deterioration and therefore cannot replace beclomethasone for the long-term treatment of such asthmatic patients.
对14名先前使用二丙酸倍氯米松治疗的常年性哮喘儿童进行了为期四个月的交叉试验,以比较胆茶碱和二丙酸倍氯米松气雾剂在控制其症状方面的疗效。通过每日两次测量峰值呼气流速以及每日记录症状评分和额外使用沙丁胺醇的情况进行评估。与单独使用倍氯米松相比,倍氯米松和口服胆茶碱联合使用可更好地控制哮喘。将倍氯米松剂量从每日400微克减少会导致哮喘恶化。口服胆茶碱并不能预防这种恶化,因此不能替代倍氯米松用于此类哮喘患者的长期治疗。